Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?
Removing Sc from the CHA2DS2VASc score does not affect its ability to discriminate thromboembolic events in the population with AF. The use of CHA2DS2VA may simplify initial decision-making for thromboprophylaxis.
Authors
- Amand F. Schmidt (ORCID: https://orcid.org/0000-0003-1327-0424)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Chris Finan (ORCID: https://orcid.org/0000-0002-3319-1937)
- Rui Providência (ORCID: https://orcid.org/0000-0001-9141-9883)
- Hiroyuki Yoshimura (ORCID: https://orcid.org/0009-0009-1991-5001)
Institutions
- University of Liverpool (GB)
- Barts Health NHS Trust (GB)
- University Medical Center Utrecht (NL)
- Liverpool Heart and Chest Hospital (GB)
- University College London (GB)
- Liverpool John Moores University (GB)
- Aalborg University (DK)
Publication Details
- Journal
- EP Europace
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1093/europace/euae280
- Citations
- 39
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 15.68
Funders
- Government of the United Kingdom
- UK Research and Innovation
- National Institute for Health and Care Research
- British Heart Foundation
- University College London
- European Commission
- HORIZON EUROPE Framework Programme